Now this statement needs to be updated (i) highlighting the correlation between STAT3 mutation, symptomatic disease and short patient survival and (ii) adding the issue of discovery of STAT5b genetic lesions also to indolent CD4+ T-LGLL and Tγδ LGLL. This evidence concerns the gene ABCA1 and T-cell large granular lymphocyte leukemia.